Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019
Synopsis

Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018

Siddharth Sridhar, Vincent C.C. Cheng, Shuk-Ching Wong, Cyril C.Y. Yip, Shusheng Wu, Anthony W.I. Lo, Kit-Hang Leung, Winger W.N. Mak, Jianpiao Cai, Xin Li, Jasper F.W. Chan, Susanna K.P. Lau, Patrick C.Y. Woo, Wai-Ming Lai, Tze-Hoi Kwan, Timmy W.K. Au, Chung-Mau Lo, Sally C.Y. Wong, and Kwok-Yung YuenComments to Author 
Author affiliations: The University of Hong Kong, Hong Kong, China (S. Sridhar, V.C.C. Cheng, S.-C. Wong, C.C.Y. Yip, S. Wu, K.-H. Leung, W.W.N. Mak, J. Cai, X. Li, J.F.W. Chan, S.K.P. Lau, P.C.Y. Woo, C.-M. Lo, S.C.Y. Wong, K.-Y. Yuen); Queen Mary Hospital, Hong Kong (A.W.I. Lo, T.W.K. Au); Princess Margaret Hospital, Hong Kong (W.-M. Lai); Tuen Mun Hospital, Hong Kong (T.-H. Kwan)

Main Article

Table 2

Summary of studies describing HEV-4 infections in immunocompromised patients

Reference Patient age, y/sex Underlying immunosuppressive condition/treatment Peak ALT, U/L Progression to persistent HEV infection Ribavirin treatment/ response Patient outcome
(37)
4/M
Acute lymphoblastic leukemia
585
Spontaneous clearance, relapsed 20 mo later
No
Spontaneous clearance of relapse; resolution of hepatitis
(36)
68/M
Liver transplantation/tacrolimus
149
Yes
Yes/yes
Required retransplantation because of accelerated liver fibrosis; patient died of hemorrhage
(35)
47/F
Liver transplantation/tacrolimus
Not reported
Yes
Yes/no
Progressive cholestasis; patient died of sepsis
(11) 52/M Renal transplantation/prednisolone, cyclosporin A, and everolimus or sirolimus
230 Yes Yes/no Ribavirin resistance; progressive cirrhosis
55/M 456 Yes Yes/yes Resolution of hepatitis

65/M
470
Yes
Yes/yes
Resolution of hepatitis
(38) 36/M Renal transplantation/ tacrolimus 300 Yes Yes/yes Relapse after ribavirin withheld; progressive hepatitis

*ALT, alanine aminotransferase; HEV, hepatitis E virus.

Main Article

References
  1. Rein  DB, Stevens  GA, Theaker  J, Wittenborn  JS, Wiersma  ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:98897. DOIPubMedGoogle Scholar
  2. Kamar  N, Selves  J, Mansuy  JM, Ouezzani  L, Péron  JM, Guitard  J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:8117. DOIPubMedGoogle Scholar
  3. Sridhar  S, Teng  JLL, Chiu  TH, Lau  SKP, Woo  PCY. Hepatitis E virus genotypes and evolution: emergence of camel hepatitis E variants. Int J Mol Sci. 2017;18:E869. DOIPubMedGoogle Scholar
  4. Lapa  D, Capobianchi  MR, Garbuglia  AR. Epidemiology of hepatitis E virus in European countries. Int J Mol Sci. 2015;16:2571143. DOIPubMedGoogle Scholar
  5. Pisano  MB, Martinez-Wassaf  MG, Mirazo  S, Fantilli  A, Arbiza  J, Debes  JD, et al. Hepatitis E virus in South America: The current scenario. Liver Int. 2018;38:153646. DOIPubMedGoogle Scholar
  6. Cossaboom  CM, Heffron  CL, Cao  D, Yugo  DM, Houk-Miles  AE, Lindsay  DS, et al. Risk factors and sources of foodborne hepatitis E virus infection in the United States. J Med Virol. 2016;88:16415. DOIPubMedGoogle Scholar
  7. Sarkar  S, Rivera  EM, Engle  RE, Nguyen  HT, Schechterly  CA, Alter  HJ, et al. An epidemiologic investigation of a case of acute hepatitis E. J Clin Microbiol. 2015;53:354752. DOIPubMedGoogle Scholar
  8. Te  HS, Drobeniuc  J, Kamili  S, Dong  C, Hart  J, Sharapov  UM. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc. 2013;45:8103. DOIPubMedGoogle Scholar
  9. Geng  Y, Zhao  C, Fan  J, Harrison  TJ, Zhang  H, Lian  H, et al. Genotype analysis of hepatitis E virus from sporadic hepatitis E cases in northern China. Infect Genet Evol. 2013;20:4137. DOIPubMedGoogle Scholar
  10. Sridhar  S, Lo  SK, Xing  F, Yang  J, Ye  H, Chan  JF, et al. Clinical characteristics and molecular epidemiology of hepatitis E in Shenzhen, China: a shift toward foodborne transmission of hepatitis E virus infection. Emerg Microbes Infect. 2017;6:e115. DOIPubMedGoogle Scholar
  11. Sridhar  S, Chan  JFW, Yap  DYH, Teng  JLL, Huang  C, Yip  CCY, et al. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong. J Viral Hepat. 2017.PubMedGoogle Scholar
  12. Colson  P, Coze  C, Gallian  P, Henry  M, De Micco  P, Tamalet  C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007;13:6489. DOIPubMedGoogle Scholar
  13. Hewitt  PE, Ijaz  S, Brailsford  SR, Brett  R, Dicks  S, Haywood  B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:176673. DOIPubMedGoogle Scholar
  14. Domanović  D, Tedder  R, Blümel  J, Zaaijer  H, Gallian  P, Niederhauser  C, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22:30514. DOIPubMedGoogle Scholar
  15. Schlosser  B, Stein  A, Neuhaus  R, Pahl  S, Ramez  B, Krüger  DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol. 2012;56:5002. DOIPubMedGoogle Scholar
  16. Pourbaix  A, Ouali  N, Soussan  P, Roque Afonso  AM, Péraldi  MN, Rondeau  E, et al. Evidence of hepatitis E virus transmission by renal graft. Transpl Infect Dis. 2017;19:e12624. DOIPubMedGoogle Scholar
  17. Sridhar  S, Yip  CCY, Wu  S, Cai  J, Zhang  AJ, Leung  KH, et al. Rat hepatitis E virus as cause of persistent hepatitis after liver transplant. Emerg Infect Dis. 2018;24:224150. DOIPubMedGoogle Scholar
  18. Jothikumar  N, Cromeans  TL, Robertson  BH, Meng  XJ, Hill  VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:6571. DOIPubMedGoogle Scholar
  19. Chan  JF, Zhang  AJ, Chan  CC, Yip  CC, Mak  WW, Zhu  H, et al. Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons. EBioMedicine. 2016;14:11222. DOIPubMedGoogle Scholar
  20. Kamar  N, Rostaing  L, Legrand-Abravanel  F, Izopet  J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant. 2013;13:19356. DOIPubMedGoogle Scholar
  21. Wen  GP, Chen  CR, Song  XY, Tang  ZM, Ji  WF, Wang  SL, et al. Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors. Emerg Microbes Infect. 2018;7:125. DOIPubMedGoogle Scholar
  22. Kraef  C, Schlein  C, Hiller  J, Westhölter  D, Denzer  U, Horvatits  T, et al. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors. J Clin Virol. 2018;105:2630. DOIPubMedGoogle Scholar
  23. Schumann  A, Lindemann  M, Valentin-Gamazo  C, Lu  M, Elmaagacli  A, Dahmen  U, et al. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation. 2009;87:10311. DOIPubMedGoogle Scholar
  24. Lo  CM, Fung  JT, Lau  GK, Liu  CL, Cheung  ST, Lai  CL, et al. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B. Hepatology. 2003;37:3643. DOIPubMedGoogle Scholar
  25. British Transplantation Guidelines. Guidelines for hepatitis E and solid organ transplantation 2017 [cited 2018 Sep 8]. https://bts.org.uk/wp-content/uploads/2017/05/BTS-HEV-Guideline-CONSULTATION_DRAFT.pdf
  26. Study Group for Viral Hepatitis. Consensus document of the diagnosis, management, and prevention of infection with the hepatitis E virus [cited 2018 Sep 22]. https://www.seimc.org/contenidos/gruposdeestudio/gehep/dcientificos/documentos/gehep-seimc-dc-2018-HepatitisE_Version_En.pdf
  27. Rivero-Juarez  A, Aguado  R, Lopez-Lopez  P, Sanchez-Frias  M, Frias  M, Briceño  J, et al. Prevalence of hepatitis E virus infection in liver donors in Spain. Clin Microbiol Infect. 2018;24:12189. DOIPubMedGoogle Scholar
  28. Tedder  RS, Tettmar  KI, Brailsford  SR, Said  B, Ushiro-Lumb  I, Kitchen  A, et al. Virology, serology, and demography of hepatitis E viremic blood donors in South East England. Transfusion. 2016;56:152936. DOIPubMedGoogle Scholar
  29. Bryan  JP, Tsarev  SA, Iqbal  M, Ticehurst  J, Emerson  S, Ahmed  A, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis. 1994;170:51721. DOIPubMedGoogle Scholar
  30. Huang  W, Zhang  H, Harrison  TJ, Lang  S, Huang  G, Wang  Y. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques. J Med Virol. 2008;80:82432. DOIPubMedGoogle Scholar
  31. Sridhar  S. Serological susceptibility of immunocompromised transplant recipients to hepatitis E infection in Hong Kong: a hepatitis E virus genotype 4 endemic region. Presented at: 17th Asia-Pacific Congress of Clinical Microbiology and Infection; 2018 Aug 30–Sep 2; Hong Kong.
  32. Mizuo  H, Yazaki  Y, Sugawara  K, Tsuda  F, Takahashi  M, Nishizawa  T, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol. 2005;76:3419. DOIPubMedGoogle Scholar
  33. Jeblaoui  A, Haim-Boukobza  S, Marchadier  E, Mokhtari  C, Roque-Afonso  AM. Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation. Clin Infect Dis. 2013;57:e1226. DOIPubMedGoogle Scholar
  34. Haffar  S, Shalimar , Kaur  RJ, Wang  Z, Prokop  LJ, Murad  MH, et al. Acute liver failure caused by hepatitis E virus genotype 3 and 4: A systematic review and pooled analysis. Liver Int. 2018;38:196573. DOIPubMedGoogle Scholar
  35. Wu  CH, Ho  CM, Tsai  JH, Sun  HY, Hu  RH, Lee  PH. First case genotype 4 hepatitis E infection after a liver transplant. Exp Clin Transplant. 2017;15:22830.PubMedGoogle Scholar
  36. Perumpail  RB, Ahmed  A, Higgins  JP, So  SK, Cochran  JL, Drobeniuc  J, et al. Fatal accelerated cirrhosis after imported HEV genotype 4 infection. Emerg Infect Dis. 2015;21:167981. DOIPubMedGoogle Scholar
  37. Geng  Y, Zhang  H, Huang  W, J Harrison  T, Geng  K, Li  Z, et al. Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon. 2014;14:e15618.PubMedGoogle Scholar
  38. Wang  Y, Chen  G, Pan  Q, Zhao  J. Chronic hepatitis E in a renal transplant recipient: the first report of genotype 4 hepatitis E virus caused chronic infection in organ recipient. Gastroenterology. 2018;154:1199201. DOIPubMedGoogle Scholar
  39. Kamar  N, Garrouste  C, Haagsma  EB, Garrigue  V, Pischke  S, Chauvet  C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:14819. DOIPubMedGoogle Scholar
  40. Zhou  X, Wang  Y, Metselaar  HJ, Janssen  HL, Peppelenbosch  MP, Pan  Q. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J Hepatol. 2014;61:74654. DOIPubMedGoogle Scholar
  41. Kamar  N, Izopet  J, Tripon  S, Bismuth  M, Hillaire  S, Dumortier  J, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:111120. DOIPubMedGoogle Scholar
  42. Pas  SD, Streefkerk  RH, Pronk  M, de Man  RA, Beersma  MF, Osterhaus  AD, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol. 2013;58:62934. DOIPubMedGoogle Scholar
  43. Cattoir  L, Van Hoecke  F, Van Maerken  T, Nys  E, Ryckaert  I, De Boulle  M, et al. Hepatitis E virus serology and PCR: does the methodology matter? Arch Virol. 2017;162:262532. DOIPubMedGoogle Scholar

Main Article

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external